Engineers Gate Manager’s Starling Oncology STLN Stock Holding History
Bought
Maintained
Sold
Other funds holding STLN
DM
JAIC
WC
Engineers Gate Manager's STLN Position: Q2 2026 in Review
Engineers Gate Manager reduced its Starling Oncology (STLN) stake by 80% in Q2 2026, selling an estimated $212K and leaving 12,342 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.
Engineers Gate Manager first reported a position in STLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $193K in Q1 2026. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.
- Engineers Gate Manager held 12,342 shares of Starling Oncology worth $67K as of Q2 2026.
- Engineers Gate Manager sold 50,452 Starling Oncology shares in Q2 2026, an estimated $212K.
- Starling Oncology made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2110 holding.
- Engineers Gate Manager first reported a position in Starling Oncology in Q4 2025 and has held it in 3 quarters since.
- Engineers Gate Manager's Starling Oncology position peaked at $193K in Q1 2026.
- 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.